All the news Showing 10 of 56 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C prevalence down by 40% since 2015 in England Keith Alcorn / 11 March 2022 The prevalence of hepatitis C in England fell by almost 40% between 2015 and 2020 and deaths due to the virus fell by 35% in the same period, the UK Health Security Agency ... Cognitive function improves after hepatitis C cure Keith Alcorn / 22 October 2021 Curing hepatitis C improves cognitive function, especially in older people already showing signs of cognitive impairment, a Spanish study has found. Cognitive impairment covers a wide spectrum of problems with memory, concentration, learning, attention ... Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... Minimal monitoring of hepatitis C treatment is safe and effective Keith Alcorn / 17 November 2020 Hepatitis C treatment with no monitoring visits during treatment is safe and leads to a high cure rate, an international study reported on Monday at the online AASLD Liver Meeting. The study was ... 13% of HIV-positive Europeans who are cured of hepatitis C are reinfected Liz Highleyman / 05 August 2019 More than one in ten HIV-positive people in the large EuroSIDA cohort who were cured of hepatitis C were reinfected within two years, according to a report last month at ... Hepatitis C does not raise risk of heart disease or cancers in people with HIV Keith Alcorn / 18 July 2019 Hepatitis C co-infection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large EuroSIDA cohort published in Clinical Infectious Diseases has found. ... Risk of Parkinson's disease lower in people treated for hepatitis C Keith Alcorn / 18 June 2019 People with hepatitis C who received interferon-based treatment were less likely to develop Parkinson’s disease, a large study from Taiwan has concluded. The results, published in JAMA Neurology, add to the evidence ... Pangenotypic hepatitis C drug combinations curing almost all people who complete treatment, real-world studies show Keith Alcorn / 12 April 2019 Once-daily combination pills that can treat all genotypes of hepatitis C infection are curing almost everyone who completes a course of treatment, and drop-out rates during treatment are low, large 'real-world' cohort ... Hepatitis C treatment appears safe and effective for pregnant women Liz Highleyman / 20 March 2019 Treatment with sofosbuvir/ledipasvir (Harvoni) was well tolerated and cured all pregnant women with hepatitis C virus (HCV), according to a study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019) ... DAA treatment reduces the risk of death and liver cancer in France Keith Alcorn / 12 February 2019 Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to results of one of the largest studies ... ← First12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive